VariLift®-LX is the only posterior stand-alone expandable lumbar interbody fusion device cleared by the FDA for 1 or 2 levels, PLIF or TLIF, with or without supplemental fixation, and intended for use with autograft and/or allograft tissue.
Benefits:
- Zero Profile Construct for True MIS, Outpatient or Inpatient: VariLift®-LX is a Zero-Profile, Minimally-Invasive Option for Patients with DDD, Grade 1 Spondylolisthesis, and Adjacent Segment Disease.
- Large Graft Chamber allows Overpacking of Fusion Material:With 4 large fenestrations and a generous bone graft chamber, VariLift®-LX is designed to allow maximum contact between graft material and endplates.
- Zero Mechanical Failures after 21k Implanted Devices: VariLift®-LX is made of titanium alloy (Ti-6Al-4V), a high-performance material well known for its strength and biocompatibility in orthopedic applications.
- Non-Impact Insertion and Multi-Plane Expansion In Situ: Designed to Help Treat Collapsed Disc Spaces and Provide Immediate Stabilization.With a leading edge as small as 6mm, the VariLift®-LX enters into the disc space in a near cylindrical shape and expands in situ. The expansion causes the device edges to gain further purchase into the cortical endplates and provide immediate stability.
- Generous Graft Chamber:Large Fenestrations for Fusion and Distribution of Bone Graft into the Disc Space.Once deployed, a large hollow inner chamber and wide fenestrations allow placement of local bone graft and ultimate growth of the intervertebral fusion throughout the implant and endplates. The device’s fenestrations allow for postoperative fusion assessment.
- Broad Clearance for Patient Optimization: VariLift provides proven clinical outcomes and fewer postoperative complications, allowing surgeons to approach any existing procedure conservatively.(Download Study)
- Mini, Open Microscope
- Unilateral TLIF, Bilateral PLIF
- 1 or 2 Level Stand-Alone
- Interbody with or without Supplemental Fixation
- Flexible Treatment Option for Adjacent Segment Disease: VariLift® boasts significant clinical success and high fusion rates for the treatment of symptomatic ASD cases. Stand-Alone adjacent level treatment is an alternative approach to reduce VAS scores and clinical symptoms without the need for supplemental fixation.(Download study).
About Wenzel Spine
Wenzel Spine, Inc. is a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders. Headquartered in Austin, TX, Wenzel Spine is focused on delivering surgical solutions that improve the overall quality of spine care by simplifying procedures and reducing recovery time. Wenzel Spine seeks to improve patient quality of life by designing and producing devices of the highest quality to support our surgeon clients in the care and treatment of their patients. For more information about the company and our products, visit www.wenzelspine.com